DOP38 A vedolizumab specific four-gene colonic signature...

Journal of Crohn's and Colitis 2019 / 01 Vol. 13; Iss. Supplement

DOP38 A vedolizumab specific four-gene colonic signature accurately predicting future endoscopic remission in patients with inflammatory bowel disease

Verstockt, B, Verstockt, S, Sudahakar, P, Dehairs, J, Blevi, H, Van Assche, G, Vermeire, S, Ferrante, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.072
Date:
January, 2019
File:
PDF, 134 KB
2019
Conversion to is in progress
Conversion to is failed